APRIL 15, 2007
VOLUME 4 NO. 7

PATIENTS & PRACTICE
WHAT TO TELL YOUR PATIENTS

Don't leave depression untreated during pregnancy


Pregnancy, supposed to be a joyous time can be a positively harrowing experience for women being treated with antidepressant drugs. The fear of harming their unborn child by continuing their medication must be weighed against the dangers of letting their condition go unchecked. You can bet they will look to you for advice on how to make this very tough decision. And what you have to say may well surprise them.

BABIES AND BLUES
Physicians once believed that pregnancy actually alleviated the symptoms of depression. Unfortunately, we now know the opposite is true. "Depression often gets worse during pregnancy, though we don't know why," says Dr Shaila Misri, co-director of the reproductive mental health program at BC Women's Hospital and Health Centre. According to Dr Don Davis, president of the Society of Obstetricians and Gynecologists of Canada (SOGC), the physical and emotional changes that occur during pregnancy can take their toll on a woman's mental health. "Just the concern of how their illness is going to affect their pregnancy and their child's health can cause distress — fatigue added to that doesn't help," he says. Hormonal changes also affect mood, of course, as can the physical changes of pregnancy. "To many of us this is a beautiful change, but there are women who are very uncomfortable with weight gain," he points out. "All these things can make pre-existing depression worse."

MATERNAL INSTINCT
As many of your patients who have suffered from or are currently living with depression can tell you, medication can be a real lifesaver — but most believe their delicate condition means they will have to suffer through their illness drug-free. Not so, says Dr Misri. "There are two issues here: exposure to medication and exposure to illness. Neither is a particularly good choice, but if you have to make it, we know that leaving the mom untreated is really not a good option," she says.

Dr Davis agrees. While the SOGC's official position is that women shouldn't use any medication during pregnancy unless it's absolutely necessary, it does recognize that if a patient's depression is serious enough to warrant medication, they're probably better off staying on it because abrupt withdrawal can be very dangerous. Even gradually tapering off, he adds, can cause problems.

"I think patients need to be reassured, they want to be as confident as they can that they're doing the best things for themselves and their baby," Dr Davis says. "Many women are ready to 'take their lumps,' that is manage their condition on their own, just so long as the baby is well. That's the wonderful thing about mothers — they're very self-sacrificing. But the danger is that they'll become overwhelmed by their underlying depression, and that doesn't serve anyone."

PROS AND CONS
The scientific literature is beginning to support that notion. "A ton of research is now showing depression itself has an adverse effect on the developing fetus," says Dr Misri. Untreated depression or anxiety during pregnancy has been shown to lead to premature labour and delivery. Women who stop taking their medication are five times more likely than women who continue it to experience a relapse, and the risk of postpartum depression also goes up. Even after birth, children can suffer from a mother's untreated condition — studies have shown that the cognitive, social and psychological development of a child can be affected.

Of course, there are also studies — and these are the ones your patients are likely to hear about — that show antidepressants can be harmful to the fetus. A small study found babies of women who took SSRIs in the second half of their pregnancy were six times more likely to have a serious breathing problem called persistent pulmonary hypertension. And a recent study showed as many as one third of babies born to mothers who took SSRIs experience short-term withdrawal, symptoms of which include tremors, increased crying and difficulty feeding. But to Dr Misri, the evidence — and her personal experience — tells her the risks to the baby aren't significant enough to warrant putting the mother at risk. "The overwhelming majority of these babies are fine — they really are. Hence the advocacy for treatment."

A BIG CAVEAT
The exception is paroxetine — Health Canada has warned pregnant women shouldn't take the drug due to an increased risk of fetal heart defects. If your patient is taking paroxetine when she becomes pregnant, you'll need to work with her to make the switch to another medication. Tricyclics also are not recommended for pregnant women.

Despite all the evidence, patients with milder symptoms of depression or those who have progressed well with treatment may insist on discontinuing their medication during pregnancy. Again, it's a very individual decision — but one that shouldn't be made without your counsel. "If you're going to discontinue medication, it must be done very gradually and the patient must be monitored closely," Dr Davis warns. "Patients should be told that they have a responsibility to their unborn child to report any adverse situations themselves, and maintain an open relationship with their physician so intervention can occur quickly if it's needed," he adds.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.